摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5''-N-(9Z,12Z-octadeca-di-ene-oyl)-1,3,2',6',2''',6'''-hexa-N-(tert-butoxycarbonyl)-5''-deoxy-neomycin | 1067241-25-1

中文名称
——
中文别名
——
英文名称
5''-N-(9Z,12Z-octadeca-di-ene-oyl)-1,3,2',6',2''',6'''-hexa-N-(tert-butoxycarbonyl)-5''-deoxy-neomycin
英文别名
tert-butyl N-[(1S,2R,3R,4S,5R)-2-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-6-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]oxan-2-yl]oxy-3-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-4,5-dihydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-6-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]oxan-2-yl]oxy-3-hydroxy-5-[[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]methyl]oxolan-2-yl]oxy-4-hydroxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]cyclohexyl]carbamate
5''-N-(9Z,12Z-octadeca-di-ene-oyl)-1,3,2',6',2''',6'''-hexa-N-(tert-butoxycarbonyl)-5''-deoxy-neomycin化学式
CAS
1067241-25-1
化学式
C71H125N7O25
mdl
——
分子量
1476.81
InChiKey
XYZSHRCNSXGWDW-JBGFGDNBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.7
  • 重原子数:
    103
  • 可旋转键数:
    42
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    436
  • 氢给体数:
    13
  • 氢受体数:
    25

反应信息

  • 作为反应物:
    描述:
    5''-N-(9Z,12Z-octadeca-di-ene-oyl)-1,3,2',6',2''',6'''-hexa-N-(tert-butoxycarbonyl)-5''-deoxy-neomycin三氟乙酸二氯甲烷 为溶剂, 反应 0.05h, 以90%的产率得到1,3,2',6',2''',6'''-hexaammonium-5''-deoxy-5''-N-(9Z,12Z-octadeca-di-ene-oyl)-neomycin hexakis(trifluoroacetate)
    参考文献:
    名称:
    Design, Synthesis, and Antibacterial Activities of Neomycin−Lipid Conjugates: Polycationic Lipids with Potent Gram-Positive Activity
    摘要:
    Aminoglycoside antibiotics and cationic detergents constitute two classes of clinically important drugs and antiseptics. Their bacteriological and clinical efficacy, however, has decreased recently due to antibiotic resistance. We have synthesized aminoglycoside-lipid conjugates in which the aminoglycoside neomycin forms the cationic headgroup of a polycationic detergent. Our results show that neomycin-C-16 and neomycin-C-20 conjugates exhibit strong Gram-positive activity but reduced Gram-negative activity. The MIC of neomycin-C-16 (C-20) conjugates against methicillin-resistant Staphylococcus aureus (MRSA) is comparable to clinically used antiseptics.
    DOI:
    10.1021/jm800345u
  • 作为产物:
    描述:
    hexa-N-Boc deoxy-neomycin-5’’-amine 、 (Z,Z)-9,12-十八烷二烯酸二聚物 在 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 N,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 2.0h, 以88%的产率得到5''-N-(9Z,12Z-octadeca-di-ene-oyl)-1,3,2',6',2''',6'''-hexa-N-(tert-butoxycarbonyl)-5''-deoxy-neomycin
    参考文献:
    名称:
    Design, Synthesis, and Antibacterial Activities of Neomycin−Lipid Conjugates: Polycationic Lipids with Potent Gram-Positive Activity
    摘要:
    Aminoglycoside antibiotics and cationic detergents constitute two classes of clinically important drugs and antiseptics. Their bacteriological and clinical efficacy, however, has decreased recently due to antibiotic resistance. We have synthesized aminoglycoside-lipid conjugates in which the aminoglycoside neomycin forms the cationic headgroup of a polycationic detergent. Our results show that neomycin-C-16 and neomycin-C-20 conjugates exhibit strong Gram-positive activity but reduced Gram-negative activity. The MIC of neomycin-C-16 (C-20) conjugates against methicillin-resistant Staphylococcus aureus (MRSA) is comparable to clinically used antiseptics.
    DOI:
    10.1021/jm800345u
点击查看最新优质反应信息